When pharmaceutical companies evaluate their state licensing compliance, the conversation often begins with a simple question: "Do we have all the licenses we need?" Unfortunately, that question...
Jessi O'Connell
Beyond the Application: Building a Successful Wholesale Distributor Licensing Strategy
Expanding pharmaceutical distribution capabilities is an exciting milestone for any organization. Whether launching a new wholesale distribution business, expanding into additional markets, or...
Expanding into Puerto Rico? Here’s What Pharmaceutical Companies Need to Know Before Entering the Market
For pharmaceutical manufacturers, wholesale distributors, virtual manufacturers, and other regulated pharma organizations, Puerto Rico represents an important extension of the U.S. marketplace....
Employee Screening for Controlled Substance Access: The Compliance Requirement Too Many Companies Take for Granted
In highly regulated pharmaceutical operations, companies invest significant time and resources into physical security, inventory controls, DEA registrations, and state licensing requirements....
Why Every Pharmaceutical Company Needs More Than One Designated Representative
Imagine receiving notice that your facility's Designated Representative has resigned effective immediately. At first glance, it may seem like a standard personnel issue. Someone leaves, you...
Podcast Episode: Medical DeviceFDA Registration Is Not a State Licensing Strategy
Jack: You've got your FDA registration squared away, your device listings current, your quality systems humming — and then a state regulator sends you a letter asking about a license you didn't know...
Still Managing Your State Licensing Portfolio in Excel? There’s a Better Way.
For decades, Excel spreadsheets have been a staple of business operations. They are flexible, familiar, and capable of organizing vast amounts of information. Within pharmaceutical companies,...
The Regulatory Changes You Don’t See Can Cost You Everything
For pharmaceutical companies, maintaining state licenses is often viewed as a routine compliance obligation. Applications are filed, renewals are submitted, fees are paid, and business moves...
The Regulatory Shift Virtual Pharmaceutical Companies Can’t Ignore
States are rethinking how virtual manufacturers and wholesalers should be licensed. Is your compliance strategy keeping up? The pharmaceutical industry has embraced a business model that...
The Real Risk of Managing a Pharmaceutical Change of Ownership
In the pharmaceutical industry, a Change of Ownership (CHOW) is far more than a business transaction. Whether a company is acquiring a facility, restructuring corporate ownership, merging...